François Meyer

Plus aucun poste en cours

Profil

François Meyer formerly worked at Sangamo Therapeutics France SAS, as Chairman & Chief Executive Officer in 2013, Centelion SAS, as Chief Executive Officer, Fonds National de La Recherche, as Chairman-Scientific Council from 2006 to 2010, BioTransplant, Inc., as Director, Systemix, Inc., as Director from 1993 to 1996, Introgen Therapeutics, Inc., as Director, SaviCorp, as Director General in 2006, Gene Therapy Systems, Inc., as Director, Urogene SA, as Director, Aventis Pharma SARL, as Director-Research & Development in 2002, BioSeek, Inc., as Director, Centre National de la Recherche Scientifique, as Director-Research in 1992, Gencell SA (France), as Managing Director, BASF Performance Products Ltd.
(United Kingdom), as Head-Molecular Genetics in 1984, Rhone Poulenc Rorer, as Corporate Senior Vice President-Global Research from 1996 to 2006, Amsterdam Molecular Therapeutics (AMT) Holding NV, as Member-Supervisory Board from 2012 to 2013, Sandoz Pharmaceuticals AG, as Member-Corporate Research Board & Vice President from 1993 to 1996, and uniQure NV, as Member-Supervisory Board from 2010 to 2014.
Dr. Meyer received his doctorate degree in 1978 from the University of Zurich and undergraduate degree in 1972 from Swiss Federal Institute of Technology.

Anciens postes connus de François Meyer

Sociétés	Poste	Fin
UNIQURE N.V.	Directeur/Membre du Conseil	01/01/2014
Amsterdam Molecular Therapeutics (AMT) Holding NV	Directeur/Membre du Conseil	11/03/2013
Urogene SA	Directeur/Membre du Conseil	17/10/2012
Fonds National de La Recherche	Corporate Officer/Principal	01/01/2010
SAVICORP	Directeur Général	01/01/2006

Formation de François Meyer

University of Zurich	Doctorate Degree
Swiss Federal Institute of Technology	Undergraduate Degree